Rapid Reviews in Hematology™: Updates from San Diego on Therapeutic Advancements in Hemolytic Anemias – A Focus on Paroxysmal Nocturnal Hemoglobinuria

CME: 1.50

February 18, 2021
KEYWORDS Primary Care
/ Print / Reprints /
| Share More
/ Text Size+

Examine emerging clinical trial evidence regarding current and emerging therapies for patients with  Paroxysmal Nocturnal Hemoglobinuria (PNH) Paroxysmal Nocturnal Hemoglobinuria

Post a comment to this article